References
- Friedman H., Klien T. W., Specter S. Drugs of abuse: Immunity and infections, , et al. CRC Press LLC, Boca Raton, FL 1996
- Ganesan S., Felo J., Saldana M., Kalasinsky V. F., Lewin‐Smith M. R., Tomashefski J. F. JR. Embolized crospovidone (poly[N‐vinyl‐2‐pyrrolidone]) in the lungs of intravenous drug users. Modern Pathology 2003; 16((4))286–292
- Hagan H., Thiede H., Weiss N. S., Hopkins S. G., Duchin J. S., Alexander E. R. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001; 91: 42–46
- Haverkos H., Lange R. Serious infections other than immunodeficiency virus among intravenous drug abusers. Journal of Infectious Diseases 1990; 161: 894–902
- Huizer H. Analytical studies on illicit heroin II. Comparison of samples. Journal of Forensic Sciences 1983; 28: 40–48
- Kaa E. Street drugs in Denmark. Journal of Forensic Sciences 1991; 36: 866–879
- Kaa E. Impurities, adulterants and diluents of illicit heroin. Changes during a 12‐year period. Forensic Science International 1994; 64: 171–179
- Low A. S. An evaluation of analytical procedures for detection of drug Abuse with particular reference to opiates, , et al, 1998, Unpublished doctoral dissertation, Robert Gordon University, Aberdeen
- Posner D., Guill A. Cutaneous foreign body granulomas associated with intravenous drug abuse. Journal of American Academy of Dermatology 1985; 13: 869–872
- Scott J., Kennedy E. J., Winfield A. J., Bond C. M. Laboratory study of the effects of citric and ascorbic acids on injections prepared with brown heroin. International Journal of Drug Policy 2000; 11: 417–422
- Shesser R., Randall J., Olshaker R. The contribution of impurities to the acute morbidity of illegal drug use. American Journal of Emergency Medicine 1991; 9: 336–342
- Siddiqui N. An amendment to section 9A of the Misuse of Drugs Act 1971 ‐to permit the supply of drug injecting paraphernalia, , et al. Home Office, London 2003, (Home Office Circular 35/2003)
- Stein M. D. Medical complications of intravenous drug use. Journal of General Internal Medicine 1990; 5: 249–257
- Sternbach G., Moran J., Eliastam M. Heroin addiction: acute presentation of medical complications. Annals of Emergency Medicine 1980; 9((3))161–169
- Taylor A., Fleming A., Rutherford J., Goldberg D. Examining the injecting practices of injecting drug users in Scotland, , et al, 2004, [Edinburgh: Scottish Executive]. Effective Interventions Unit
- Taylor R. B., Low A. S., Reid R. G. Determination of opiates in urine by capillary electrophoresis. Journal of Chromatography B: Biomedical Applications 1996; 675: 213–223
- Thorpe L. E., Ouellet L. J., Hershow R., Bailey S. L., Williams J. W., Williamson J. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 2002; 155: 645–653
- Wills S. Adverse consequences of drug injecting. Drugs of abuse, , et al. Pharmaceutical Press, London 1997; 11–20